NRD
ETNB

Nebula Research & Development’s 89bio ETNB Stock Holding History

Nebula Research & Development’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-18,559
Closed -$207K – 808
2023
Q4 		$207K Buy
+18,559
New +$171K 0.06% 544

Other funds holding ETNB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Nebula Research & Development's ETNB Position: Q1 2024 in Review

Nebula Research & Development sold out of 89bio (ETNB) in Q1 2024, closing a stake of 18,559 shares — an estimated $207K sold.

Nebula Research & Development first reported a position in ETNB in Q4 2023 and held it in 1 quarter. The position peaked at $207K in Q4 2023. 150 funds tracked by Wall St. Rank hold ETNB as of Q1 2024.

  • Nebula Research & Development reported no remaining 89bio position as of Q1 2024 after selling out during the quarter.
  • Nebula Research & Development sold 18,559 89bio shares in Q1 2024, an estimated $207K.
  • Nebula Research & Development first reported a position in 89bio in Q4 2023 and held it in 1 quarter.
  • Nebula Research & Development's 89bio position peaked at $207K in Q4 2023.
  • 150 funds tracked by Wall St. Rank held 89bio as of Q1 2024.

Based on Nebula Research & Development's 13F filing for Q1 2024, filed 15 May 2024.